Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1840 of 6351
-
New hope for tough psoriasis spots: tildrakizumab under the microscope
Disease control OngoingPsoriasis is a chronic inflammatory disease that affects between 2% and 4% of the French population.Some specific localizations are more difficult to manage, such as the scalp, nails, genital region and palmoplantar localizations. Tildrakizumab, an anti-interleukin-23 (IL-23) mo…
Sponsor: Clin4all • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Real-world study explores new drug for breast cancer
Disease control Recruiting nowTo evaluate the efficacy and safety of Disitamab vedotin (RC48-ADC) in patients with breast cancer.
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:08 UTC
-
New pill combo aims to keep advanced breast cancer in check
Disease control Recruiting nowTo compare the efficacy and safety of capecitabine and cyclophosphamide (XC) versus physician's choice as maintenance therapy for patients with advanced breast cancer who achieved disease control after salvage treatment.
Sponsor: Wenjin Yin • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New artificial disc aims to replace fusion for neck disc disease
Disease control OngoingA multicenter, prospective, non-randomized, historically controlled study. To demonstrate the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) to treat cervical degenerative disc disease (DDD) in subjects who are sympto…
Sponsor: Synergy Spine Solutions • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Second chance for hepatitis c cure: new trial tests best retreatment
Disease control By invitation onlyThis trial is linked to a largescale observational study determining the efficacy of sofosbuvir/daclatasvir in people in Pakistan (involving a separate protocol). The observational study will identify a cohort of patients who have not responded to first-line antiviral therapy (so…
Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a common antibiotic help calm dangerous IPF Flare-Ups?
Disease control Recruiting nowThis randomized controlled trial evaluates the therapeutic role of azithromycin in acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF). Baseline severity classification and stratification were performed using the SCALE-IPF framework (Severity Classification and Lung Eva…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New mHealth program aims to lower depression and stress in black pregnant women
Knowledge-focused OngoingPerinatal Mood and Anxiety Disorders (PMADs) encompass a range of mental health disorders that occur during pregnancy and up to one year postpartum. Approximately 13% of women experience PMADs. This rate doubles for those with adverse perinatal outcomes (APO) and triples in Black…
Phase 2/3 • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New pulse therapy for depression put to the test
Symptom relief CompletedTranscranial pulse stimulation (TPS) is a newly developed brain stimulation therapy from Austria \& Germany with highly promising applicability in neuropsychiatric disorders. Major depressive disorder (MDD) is the world's leading cause of disability. Novel treatment approaches ar…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can a Low-Dose drug delay menopause? new trial aims to find out
Disease control OngoingThe investigators are proposing a prospective, randomized, double-blind, placebo-controlled pilot study assessing the ability of low-dose rapamycin to delay ovarian aging in women. Animal studies have shown the potential of rapamycin in slowing or reversing some age-associated pa…
Phase 2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
School exercise program aims to solve sleep struggles in autistic kids
Symptom relief CompletedSleep problems are very common in children on the autism spectrum and can worsen daytime behaviour, learning, and family stress. Many families have limited access to specialist sleep services. This study evaluates a school-based, sensory-friendly physical activity program designe…
Sponsor: Xili Wen • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
MRNA vaccine takes on glioblastoma in first human trial
Disease control CompletedThis study is an open-label, first-in-human, dose-escalation study of CV09050101 mRNA vaccine (CVGBM) in patients with newly diagnosed "MGMT-unmethylated" Glioblastoma (GBM). Patients with isocitrate dehydrogenase (IDH)-wildtype astrocytoma with a molecular signature of "unmethyl…
Phase 1 • Sponsor: CureVac • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Spinal magnetic stimulation plus treadmill training shows promise for Parkinson's gait
Symptom relief CompletedGait changes appear and become the main cause of disability, loss of independence, falls, fractures and reduced quality of life for patients with Parkinson Disease. Optimal gait management is complex and challenging. Some characteristics, such as gait variability, postural instab…
Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can pressurized oxygen clear long COVID brain fog?
Symptom relief Recruiting nowPost-COVID-19 syndrome is an assembly of symptoms, following an infection with Coronavirus disease 2019 (COVID-19). The syndrome is characterized by cognitive impairment, fatigue, sleep disorders, smell and taste disorders, pain and more. This long-term sequela can last for month…
Sponsor: Assaf-Harofeh Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New group therapy aims to curb suicide risk in active duty troops
Symptom relief OngoingInvestigators will evaluate a group format adaptation of Brief Cognitive-Behavioral Therapy for Suicide (i.e., G-BCBT) on suicide ideation (Aim 1), ability to use coping strategies (Aim 2), and overall mental health (exploratory analysis). The combination of tailored means safety…
Sponsor: University of North Carolina, Charlotte • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could VR help autistic young adults master social cues?
Symptom relief CompletedThe goal of this clinical trial is to evaluate whether the MyRAKAN Autism module, which integrates video modelling and spherical video-based virtual reality (SVVR), can improve social communication skills in autistic young adults. The main questions it aims to answer are: Does …
Sponsor: National University of Malaysia • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Which colonoscopy prep is kinder to kids with IBD? a trial puts two to the test
Disease control CompletedChildren hospitalized at the Department of Pediatric Gastroenterology and Nutrition at the Medical University of Warsaw with suspected or confirmed inflammatory bowel disease (IBD) will be invited to participate in the study. Data regarding demographics, current body weight, hei…
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Shorter PTSD therapy may be just as effective for veterans
Symptom relief OngoingTrauma-related guilt is common and impairing among trauma survivors, particularly among Veterans with posttraumatic stress disorder (PTSD). The investigators' work shows that a brief treatment targeting trauma-related guilt, Trauma Informed Guilt Reduction Therapy (TrIGR), can re…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy aims to fight rare nasal cancer before surgery
Disease control CancelledSinonasal mucosal malignant melanoma (SNMM) is a nasal and paranasal sinus malignancy with a low incidence and extremely poor prognosis, exhibiting specificity in Asian populations. For resectable SNMM, the efficacy of neoadjuvant immunotherapy is unclear. This prospective clinic…
Phase 2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Brain zap video game: could it sharpen your mind?
Symptom relief Recruiting nowThe goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in older adults with and without cognitive impairment. The main questions it aims to answer are: * whether it is possible to restore various cog…
Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can software make hospital pharmacists faster and safer?
Knowledge-focused CompletedAdverse drug events (ADE) are common and dangerous in the hospital and following discharge to the ambulatory setting. One cause of ADEs in both settings is medication regimen inappropriateness, including polypharmacy, drug-drug interactions, and medications that are inappropriate…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC